Table 5.

Section V results: follow-up

	Median (IQR)	Agreement (%)	Result
34. The follow-up to be performed must be defined by the MDC	8 (7–9)	85.4	First round agreement
35. In order to avoid repetitions and redundancies, each center must establish a consensual protocol to define which specialties or units assume the follow-up of the different types of patients and in the different phases	9 (8–9)	95.5	First round agreement
36. Each patient should have a specific physician responsible for his/her follow-up	9 (8–9)	92.1	First round agreement
37. If in palliative care, the patient should be treated by medical oncology specialists	7 (5–8)	57.8	No agreement
38. The medical oncology specialist will decide as to when the patient will receive symptomatic palliative care within a palliative care program	9 (7–9)	87.6	First round agreement
39. Participation in the multidisciplinary tumor committee of an endocrinology / nutrition specialist for screening and nutritional assessment, preoperative immunonutrition and nutritional support, as well as its involvement in the follow-up of all patients for the control of diabetes, pancreatic insufficiency and vitamin deficiencies, as appropriate	8 (6.5–9)	75.3	First round agreement

IQR interquartile range